- Alkermes' narcolepsy Phase 3 success; Boehringer's antibody dealPlus, news from Vistagen, Enterprise Therapeutics, Cerevance and Memento Medicines. 😴 Alkermes’ narcolepsy drug succeeds in Phase 3 study: The company’s drug Lumryz, approved in 2023 for narcole…Endpoints · 2mo ago↗ source
- Knit Health raises $11.6M for 'fundamentally different' approach to healthcare AIA startup that spun out of UC Berkeley aims to improve healthcare operations by getting AI to think like a doctor would. Knit Health launched with $11.6 million in seed funding co-led by Uncork C…Endpoints · 2mo ago↗ source
- Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billion<figure><div><img src="https://imgproxy.divecdn.com/d3kyAOKiV4alroZs496u4_W_RA0u2QbwRQbzfwY4ALY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNjg5NTg1NDg3X3JmN…